306 related articles for article (PubMed ID: 2512365)
21. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.
Meluleni GJ; Grout M; Evans DJ; Pier GB
J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254
[TBL] [Abstract][Full Text] [Related]
22. Anticore endotoxin F(ab')2 equine immunoglobulin fragments protect against lethal effects of gram-negative bacterial sepsis.
Dunn DL; Mach PA; Condie RM; Cerra FB
Surgery; 1984 Aug; 96(2):440-6. PubMed ID: 6379963
[TBL] [Abstract][Full Text] [Related]
23. Opsonization of mucoid and non-mucoid Pseudomonas aeruginosa by serum from patients with cystic fibrosis assessed by a chemiluminescence assay.
LeBlanc CM; Bortolussi R; Issekutz AC; Gillespie T
Clin Invest Med; 1982; 5(2-3):125-8. PubMed ID: 6811181
[TBL] [Abstract][Full Text] [Related]
24. Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch.
Tosi MF; Zakem H; Berger M
J Clin Invest; 1990 Jul; 86(1):300-8. PubMed ID: 2164045
[TBL] [Abstract][Full Text] [Related]
25. Isolation and characterization of circulating immune complexes in cystic fibrosis.
Moss RB; Hsu YP
Clin Exp Immunol; 1982 Feb; 47(2):301-8. PubMed ID: 6804143
[TBL] [Abstract][Full Text] [Related]
26. Association with phagocytic inhibition of anti-Pseudomonas aeruginosa immunoglobulin G antibody subclass levels in serum from patients with cystic fibrosis.
Shryock TR; Mollé JS; Klinger JD; Thomassen MJ
J Clin Microbiol; 1986 Mar; 23(3):513-6. PubMed ID: 3082922
[TBL] [Abstract][Full Text] [Related]
27. Immunology of Pseudomonas aeruginosa infection in cystic fibrosis.
Høiby N; Pedersen SS; Jensen ET; Pressler T; Shand GH; Kharazmi A; Döring G
Acta Univ Carol Med (Praha); 1990; 36(1-4):16-21. PubMed ID: 2130683
[TBL] [Abstract][Full Text] [Related]
28. A multicenter vaccine trial using the Pseudomonas aeruginosa flagella vaccine IMMUNO in patients with cystic fibrosis.
Döring G; Dorner F
Behring Inst Mitt; 1997 Feb; (98):338-44. PubMed ID: 9382758
[TBL] [Abstract][Full Text] [Related]
29. Strategies of Pseudomonas aeruginosa to colonize and to persist in the cystic fibrosis lung.
Kubesch P; Lingner M; Grothues D; Wehsling M; Tümmler B
Scand J Gastroenterol Suppl; 1988; 143():77-80. PubMed ID: 3133755
[TBL] [Abstract][Full Text] [Related]
30. Cystic fibrosis pseudomonas opsonins. Inhibitory nature in an in vitro phagocytic assay.
Fick RB; Naegel GP; Matthay RA; Reynolds HY
J Clin Invest; 1981 Oct; 68(4):899-914. PubMed ID: 6793632
[TBL] [Abstract][Full Text] [Related]
31. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
Tümmler B; Bosshammer J; Breitenstein S; Brockhausen I; Gudowius P; Herrmann C; Herrmann S; Heuer T; Kubesch P; Mekus F; Römling U; Schmidt KD; Spangenberg C; Walter S
Behring Inst Mitt; 1997 Feb; (98):249-55. PubMed ID: 9382747
[TBL] [Abstract][Full Text] [Related]
32. Proteolysis of purified IgGs by human and bacterial enzymes in vitro and the detection of specific proteolytic fragments of endogenous IgG in rheumatoid synovial fluid.
Ryan MH; Petrone D; Nemeth JF; Barnathan E; Björck L; Jordan RE
Mol Immunol; 2008 Apr; 45(7):1837-46. PubMed ID: 18157932
[TBL] [Abstract][Full Text] [Related]
33. Host inflammatory responses to first isolation of Pseudomonas aeruginosa from sputum in cystic fibrosis.
Elborn JS; Cordon SM; Shale DJ
Pediatr Pulmonol; 1993 May; 15(5):287-91. PubMed ID: 8327287
[TBL] [Abstract][Full Text] [Related]
34. Limited cleavage of human immunoglobulins by elastase of human neutrophil polymorphonuclear granulocytes. Possible modulator of immune complex disease.
Folds JD; Prince H; Spitznagel JK
Lab Invest; 1978 Oct; 39(4):313-21. PubMed ID: 81354
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients.
Ratjen F; Walter H; Haug M; Meisner C; Grasemann H; Döring G
Pediatr Pulmonol; 2007 Mar; 42(3):249-55. PubMed ID: 17243185
[TBL] [Abstract][Full Text] [Related]
36. [Extracellular toxins of Pseudomonas aeruginosa. II. Effect of two proteases on human immunoglobulins IgG, IgA and secretory IgA (author's transl)].
Döring G; Obernesser HJ; Botzenhart K
Zentralbl Bakteriol A; 1981 Mar; 249(1):89-98. PubMed ID: 6791405
[TBL] [Abstract][Full Text] [Related]
37. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis.
Burns JL; Gibson RL; McNamara S; Yim D; Emerson J; Rosenfeld M; Hiatt P; McCoy K; Castile R; Smith AL; Ramsey BW
J Infect Dis; 2001 Feb; 183(3):444-52. PubMed ID: 11133376
[TBL] [Abstract][Full Text] [Related]
38. Passive immunisation against Pseudomonas aeruginosa recombinant flagellin in an experimental model of burn wound sepsis.
Faezi S; Sattari M; Mahdavi M; Roudkenar MH
Burns; 2011 Aug; 37(5):865-72. PubMed ID: 21334822
[TBL] [Abstract][Full Text] [Related]
39. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients.
Pier GB
Behring Inst Mitt; 1997 Feb; (98):350-60. PubMed ID: 9382760
[TBL] [Abstract][Full Text] [Related]
40. IgG subclasses and chronic bacterial infection. Subclass antibodies and the clinical course of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.
Pressler T
APMIS Suppl; 1996; 66():1-41. PubMed ID: 8972694
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
